Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer

Table 4

The target genes that inferred from CLIP-Seq, RIP-Seq, CHIP-Seq, or mass spectrometry.

Binding
Species	Cell line	Class	WER name	Target gene	Interaction	Method	Downstream effect
Human	HeLa	Writer	VIRMA	LMAN2	Protein-protein	Mass spectrometry	Methylation
Human	HEK293T	Reader	IGF2BP1	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HEK293T	Reader	IGF2BP3	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HEK293T	Reader	YTHDC1	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HEK293T	Reader	YTHDF1	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HeLa	Writer	VIRMA	LMAN2	Protein-protein	Mass spectrometry	Methylation
Human	HEK293T	Reader	IGF2BP1	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HEK293T	Reader	IGF2BP3	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HEK293T	Reader	YTHDC1	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HEK293T	Reader	YTHDF1	LMAN2	Protein-RNA	CLIP-Seq	No evidence
Human	HeLa	Writer	VIRMA	LMAN2	Protein-protein	Mass spectrometry	Methylation

WERs: writers, erasers, and readers. “Protein-RNA” represents the genes inferred from various kinds of CLIP-Seq or RIP-Seq. “Protein-DNA” refers to the CHIP-Seq results, while “protein-protein” means targets summarized from mass spectroscopy results.